Cargando…
Exclusion of older adults and immunocompromised individuals in influenza, pneumococcal and COVID-19 vaccine trials before and after the COVID-19 pandemic
BACKGROUND: Older adults and immunocompromised individulas are often excluded from vaccine trials. AIM: We hypothesised that during the coronavirus disease 2019 (COVID-19) pandemic, the proportion of trials excluding these patients decreased. METHODS: Using the US Food and Drug Administration and an...
Autores principales: | Bukan, Katrine, Pearce-Slade, Toby, Eiberg, Mads, Tinelli, Marco, Yahav, Dafna, Tuells, Jose, Epaulard, Olivier, Holler, Jon G., Roed, Casper, Søborg, Christian, Jensen, Jens-Ulrik Stæhr, Harboe, Zitta Barrella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080508/ https://www.ncbi.nlm.nih.gov/pubmed/37027085 http://dx.doi.org/10.1007/s40520-023-02380-4 |
Ejemplares similares
-
Vaccination Coverage among Prisoners: A Systematic Review
por: Vicente-Alcalde, Nancy, et al.
Publicado: (2020) -
High titers of neutralizing SARS-CoV-2 antibodies six months after symptom onset are associated with increased severity in COVID-19 hospitalized patients
por: Sejdic, Adin, et al.
Publicado: (2023) -
First wave of COVID-19 hospital admissions in Denmark: a Nationwide population-based cohort study
por: Holler, Jon Gitz, et al.
Publicado: (2021) -
Dracunculiasis in South Sudan
por: Fabiansen, Christian, et al.
Publicado: (2010) -
COVID-19 in special populations
por: Yahav, Dafna
Publicado: (2022)